Communications with Federal Executive Branch

CMS

Centers for Medicare and Medicaid Services

COVID-19 Public Health Emergency Interim Final Rule Comments (PDF) June 1, 2020

Medicare Scope of Practice Request for Information – PA/APRN Coalition Letter (PDF) (January 2020)

Medicare Scope of Practice Request for Information – AAPA Comments (PDF) (January 17, 2020)

Medicare Scope of Practice Request for Information – Constituent Organization Sign-On Letter (PDF) (January 17, 2020)

2020 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule (PDF) (Sept. 26, 2019)

2020 Physician Fee Schedule Proposed Rule (PDF) (Sept. 24, 2019)

Patients Over Paperwork (PDF) (August 12, 2019)

Incident-To Sign-On Letter (PDF) (June 27, 2019)

FY 2020 Hospice Proposed Rule Comments (PDF) (June 18, 2019)

Interoperability and Patient Access Comments (PDF) (June 3, 2019)

PAs Providing Hospice Services Under Medicare (PDF) (April 10, 2019)

Medicaid Managed Care Comments (PDF) (Jan. 14, 2019)

Medicare and Medicaid Burden Reduction Comments (PDF) (Nov. 19, 2018)

Medicare and Medicaid Burden Reduction Sign-On Letter (PDF) (Nov. 2018)

ACO Proposed Rule Comments (PDF) (Oct. 16, 2018)

Outpatient Prospective Payment System (OPPS) Comments to CMS (PDF) (Sept. 24, 2018)

2019 Physician Fee Schedule and Quality Payment Program Proposed Rule (PDF) (Sept. 10, 2018)

Hospice Comments to CMS (PDF) (June 26, 2018)

IRF Comments to CMS (PDF) (June 26, 2018)

Hospital IPPS Comments (PDF) (June 25, 2018)

AAPA Comments to CMS on Medicare Advantage (PDF) (Jan. 16, 2018)

AAPA Comments to CMS on Innovation Center New Direction Request for Information (PDF) (Nov. 20, 2017)

AAPA Comments to CMS on Proposed 2018 Physician Fee Schedule (PDF) (Sept. 11, 2017)

AAPA Comments to CMS on Proposed 2018 Outpatient Prospective Payment Program (PDF) (Sept. 11, 2017)

AAPA Comments to CMS on Proposed 2018 Updates to Medicare’s Quality Payment Program (PDF) (Aug. 21, 2017)

AAPA Comments to CMS on Episode-Based Cost Measure Development for the Quality Payment Program (PDF) (April 24, 2017)

AAPA Comments to CMS on Qualified Practitioners Status for Prosthetics & Orthotics (PDF) (March 13, 2017)

AAPA Comments to CMS on MACRA Final Rule (PDF) (Dec. 16, 2016)

AAPA Comments to CMS on Proposed PACE Rule (PDF) (Oct. 17, 2016)

AAPA Comments to CMS on Episode Payment Models (PDF) (Oct. 3, 2016)

AAPA Comments to CMS on Medicare Proposed 2017 Physician Fee Schedule (PDF) (Sept. 6, 2016)

AAPA Comments to CMS on Medicare’s Proposed Rule on Hospital Outpatient Prospective Payment (PDF) (Sept. 6, 2016)

AAPA Comments to CMS on Changes to Promote Innovation, Flexibility, and Improvement in Patient Care (PDF) (Aug. 15, 2016)

AAPA Comments to CMS on Patient Relationship Categories and Codes (PDF) (Aug. 15, 2016)

AAPA Comments to CMS on MACRA and the Quality Payment Program (PDF) (June 27, 2016)

AAPA Comments to CMS re: Request for Information on Data Metrics and Alternative Processes for Access to Care in the Medicaid Program (PDF) (Jan. 4, 2016)

AAPA Comments to CMS re: Network Adequacy (PDF) (Dec. 21, 2015)

AAPA Comments to CMS re: Request for Information on Merit-Based Incentive Payment System (PDF) (Nov. 17, 2015)

AAPA Comments to CMS re: Proposed Reform of Requirements for Long-Term Care Facilities (PDF) (Sept. 14, 2015)

AAPA Comments to CMS re: Proposed Medicare 2016 Physician Fee Schedule (PDF) (Sept. 9, 2015)

AAPA Comments to CMS re: Medicaid Managed Care (PDF) (July 27, 2015)

AAPA Comments to CMS re: FY 2016 Hospice Wage Index and Payment Rate and Hospice Quality Reporting Requirements (PDF) (June 26, 2015)

AAPA Comments to CMS re: EHR Incentive Program (PDF) (May 28, 2015)

AAPA Comments to CMS re: Medicare Shared Savings Program: Accountable Care Organizations (PDF) (Feb. 6, 2015)

AAPA Comments to CMS re: Proposed Medicare 2015 Physician Fee Schedule (PDF) (Sept. 2, 2014)

AAPA Comments to CMS re: Proposed Medicare 2015 Hospital Outpatient Prospective Payment System Rule (PDF) (Sept. 2, 2014)

AAPA Comments to CMS re: Proposed 2015 Home Health Prospective Payment System Rate Update (PDF) (Aug. 27, 2014)

AAPA Letter to CMS Administrator Tavenner re: Sunshine Act CME-CE Exemption (PDF) (Aug. 22, 2014)

CMS RUC and CPT Sign-On Letter (PDF) (Aug. 13, 2014)

AAPA Comments to CMS re: DME (PDF) (July 28, 2014)

AAPA Letter to CMS re: Sunshine Act Proposed Regulations (PDF) (Aug. 27, 2013)

Joint AAPA/AANP Letter to CMS re: Sunshine Act Proposed Regulations (PDF) (Nov. 15, 2013)

SAMHSA

Substance Abuse and Mental Health Services Administration

AAPA Comments to SAMHSA on CARA PA Educational Requirements (PDF) (Oct. 31, 2016)

AAPA Comments to SAMHSA on Medication-Assisted Treatment for Opioid Use Disorders (PDF) (May 23, 2016)

Other Agencies

Other Agencies (White House, CDC, DEA, FDA, FTC, HRSA, OPM, etc.)

Communication with White House in Relation to Federal COVID-19 Response (PDF) (April 21, 2020)

OMB Letter on VA-Related Items in FY2020 Budget (PDF) (December 20, 2018)

Opioid Overdose Crisis Sign-On Letter to Dept. of Justice (PDF) (July 3, 2018)

OCAN Sign-On Letter on USPSTF Obesity Recommendations (PDF) (March 19, 2018)

AAPA Letter to FDA on The Opioid Policy Steering Committee (PDF) (December 28, 2017)

AAPA Letter to OMB on FY19 Budget Proposal Inclusions Relating to the VA (PDF) (December 29, 2017)

Letter to President’s Commission on Combating Drug Addiction and the Opioid Crisis (PDF) (Sept. 5, 2017)

Sign-On Letter to President Trump on Vaccine Safety (PDF) (Feb. 7, 2017)

AAPA Letter to Trump Transition Team (PDF) (Dec. 23, 2016)

AAPA Comments to OMB on CARA Waiver Form for PAs and NPs (PDF) (Dec. 21, 2016)

AAPA Comments to SSA on PAs as Acceptable Medical Sources Regarding Medical Evidence of Disability (PDF) (Nov. 8, 2016)

AAPA Comments to MedPAC on PAs and Telemedicine (PDF) (Mar. 10, 2016)

AAPA Response to CDC re: Proposed 2016 Guideline for Prescribing Opioids for Chronic Pain (PDF) (Jan. 11, 2016)

AAPA Letter to the Acting Director of OPM re: Federally Employed PAs (Nov. 13, 2015)

AAPA Comments to FTC re: Examining Healthcare Competition Workshop (PDF) (April 30, 2014)

AAPA Comments to DEA re: Proposed Rule on Hydrocodone Rescheduling (PDF) (April 16, 2014)

AAPA Comments to FDA on Hydrocodone and Schedule II (PDF) (Feb. 1, 2013)